SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Camlin Fine Sciences - Quaterly Results

12 Nov 2021 Evaluate
A decrease in the sales to Rs. 1381.66 millions was observed for the quarter ended September 2021. The sales stood at Rs. 1467.77 millions during the similar quarter previous year.The Net Loss for the quarter ended September 2021 is Rs. -69.91 millions as compared to Net Loss of Rs. -10.17 millions of corresponding quarter ended September 2020A decline of 39.59 millions was observed in the OP in the quarter ended September 2021 from 84.15 millions on QoQ basis.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202109 202009 % Var 202109 202009 % Var 202103 202003 % Var
Sales 1381.66 1467.77 -5.87 2838.95 2679.46 5.95 6000.48 5797.79 3.50
Other Income 10.09 13.25 -23.85 48.41 23.16 109.02 77.16 240.64 -67.94
PBIDT 39.59 84.15 -52.95 269.73 256.84 5.02 695.88 798.79 -12.88
Interest 74.86 59.10 26.67 170.92 145.17 17.74 347.85 241.71 43.91
PBDT -35.27 25.05 -240.80 98.81 106.64 -7.34 343.00 525.67 -34.75
Depreciation 66.22 33.82 95.80 130.63 64.40 102.84 192.83 112.82 70.92
PBT -101.49 -8.77 1057.24 -31.82 42.24 -175.33 150.17 412.85 -63.63
TAX -31.58 1.40 -2355.71 -9.25 14.34 -164.50 67.37 105.64 -36.23
Deferred Tax -13.23 2.95 -548.47 -3.44 6.69 -151.42 39.58 30.64 29.18
PAT -69.91 -10.17 587.41 -22.57 27.90 -180.90 82.80 307.21 -73.05
Equity 127.60 121.29 5.20 127.60 121.29 5.20 127.50 121.25 5.15
PBIDTM(%) 2.87 5.73 -50.02 9.50 9.59 -0.88 11.60 13.78 -15.83

Camlin Fine Sciences Share Price

132.20 0.35 (0.27%)
05-May-2026 12:24 View Price Chart
Peers
Company Name CMP
BASF India 3631.50
Tata Chemicals 800.50
SRF 2530.00
Pidilite Inds. 1359.95
Deepak Nitrite 1765.80
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×